Public Health | March 22, 2022
MFine brings Blood Pressure and Glucose Monitoring on smartphones
Enables millions of Indians to monitor their vitals without the need of any additional device
Enables millions of Indians to monitor their vitals without the need of any additional device
The investment will accelerate the overall Sarclisa development program
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
Around 85% of ALS patients suffer from a progressive loss of bulbar functionality
WuXi STA’s drug product site in Wuxi City offers a full range of services including formulation development and manufacturing for a broad range of oral and injectable dosage forms
Scientists worldwide have started employing wastewater analysis as an efficient and cost-effective approach for assessing the dynamics of the virus in a population. Several scientific methods are being developed to rapidly decode the message carried by sewage
TruPharma has commenced commercial marketing of Sage's approved generic cartridge product
The company, already scaling across Europe, plans to accelerate the deployment of its medication reconciliation platform in the United States
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage
Subscribe To Our Newsletter & Stay Updated
